Who
CHURCH KEVIN
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, LeonaBio.
In numbers
- Trades disclosed
- 62
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $56K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Feb 2021
- Last trade
- 9 Apr 2026
- Last filed
- 13 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $7,2981,359 at $5.37 | filing |
| 4 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $7,2981,359 at $5.37 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —5,856 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —5,856 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —5,856 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —5,856 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | Athira PharmaBiotechnology | SEC FORM 4 Sold | $6,027876 at $6.88 | filing |
| 2 Jan 2026filed 5 Jan 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $6,027876 at $6.88 | filing |
| 31 Dec 2025filed 5 Jan 2026 | Athira PharmaBiotechnology | SEC FORM 4 Code M | —3,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —3,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | Athira Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —3,667 at $0.00 | filing |
| 24 Dec 2025filed 29 Dec 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,138 at $0.00 | filing |
| 18 Nov 2025filed 5 Jan 2026 | Athira PharmaBiotechnology | SEC FORM 4 Code A | $2,3101,000 at $2.31 | filing |
| 18 Nov 2025filed 5 Jan 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code A | $2,3101,000 at $2.31 | filing |
| 1 Jul 2025filed 2 Jul 2025 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $2,4738,526 at $0.29 | filing |
| 30 Jun 2025filed 2 Jul 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —36,666 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —36,666 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.